MapLight Therapeutics Inc. (MPLT) completed its initial public offering of 16,962,500 shares of common stock at $17.00 per share, including the full exercise of underwriters’ op ...
MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating ...
MapLight Therapeutics, Inc. ( ($MPLT) ) has issued an announcement. MapLight Therapeutics, Inc. successfully closed its initial public offering ...
MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced the ...
MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback